Potential biomarkers of ductal carcinoma in situ progression.

Raquel Spinassé DettogniElaine SturAna Carolina LausRené Aloísio da Costa VieiraMárcia Maria Chiquitelli MarquesIara Viana Vidigal SantanaJosé Zago PulidoLaura Fregonassi RibeiroNarelle de Jesus ParmanhaniLidiane Pignaton AgostiniRaquel Silva Dos ReisEldamária de Vargas Wolfgramm Dos SantosLyvia Neves Rebello AlvesFernanda Mariano GarciaJéssica Aflávio SantosDiego do Prado VentorimRui Manuel ReisIúri Drumond Louro

Published in: BMC cancer (2020)

We propose these three genes (FGF2, GAS1, and SFRP1) as potential biomarkers of ductal carcinoma in situ progression, suggesting that their downregulation may be involved in the transition of stationary to migrating invasive epithelial cells.

Keyphrases

cell proliferation
genome wide
signaling pathway
liquid chromatography
room temperature
gene expression
mass spectrometry
carbon dioxide
transcription factor
ionic liquid
genome wide analysis